172 related articles for article (PubMed ID: 35684471)
1. Portuguese Propolis Antitumoral Activity in Melanoma Involves ROS Production and Induction of Apoptosis.
Oliveira RD; Celeiro SP; Barbosa-Matos C; Freitas AS; Cardoso SM; Viana-Pereira M; Almeida-Aguiar C; Baltazar F
Molecules; 2022 May; 27(11):. PubMed ID: 35684471
[TBL] [Abstract][Full Text] [Related]
2. Phenolic Compounds Contribution to Portuguese Propolis Anti-Melanoma Activity.
Caetano AR; Oliveira RD; Celeiro SP; Freitas AS; Cardoso SM; Gonçalves MST; Baltazar F; Almeida-Aguiar C
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049869
[TBL] [Abstract][Full Text] [Related]
3. Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization.
Fattore L; Malpicci D; Milite C; Castellano S; Sbardella G; Botti G; Ascierto PA; Mancini R; Ciliberto G
Cell Commun Signal; 2020 Sep; 18(1):150. PubMed ID: 32933538
[TBL] [Abstract][Full Text] [Related]
4. ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells.
Cesi G; Walbrecq G; Zimmer A; Kreis S; Haan C
Mol Cancer; 2017 Jun; 16(1):102. PubMed ID: 28595656
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo.
Niessner H; Burkard M; Leischner C; Renner O; Plöger S; Meraz-Torres F; Böcker M; Hirn C; Lauer UM; Venturelli S; Busch C; Sinnberg T
Cells; 2022 Apr; 11(7):. PubMed ID: 35406796
[TBL] [Abstract][Full Text] [Related]
6. The oxidoreductase p66Shc acts as tumor suppressor in BRAFV600E-transformed cells.
Furlan T; Khalid S; Nguyen AV; Günther J; Troppmair J
Mol Oncol; 2018 Jun; 12(6):869-882. PubMed ID: 29624862
[TBL] [Abstract][Full Text] [Related]
7. Novel chloroquine derivative suppresses melanoma cell growth by DNA damage through increasing ROS levels.
Li J; Long J; Zhang J; Liu N; Yan B; Tang L; Chen X; Peng C
J Cell Mol Med; 2022 May; 26(9):2579-2593. PubMed ID: 35332658
[TBL] [Abstract][Full Text] [Related]
8. Icariside II overcomes BRAF inhibitor resistance in melanoma by inducing ROS production and inhibiting MITF.
Liu X; Li Z; Li M; Chai J; He S; Wu J; Xu J
Oncol Rep; 2020 Jul; 44(1):360-370. PubMed ID: 32319656
[TBL] [Abstract][Full Text] [Related]
9. The chemical composition and events related to the cytotoxic effects of propolis on osteosarcoma cells: A comparative assessment of Colombian samples.
Mora DPP; Santiago KB; Conti BJ; de Oliveira Cardoso E; Conte FL; Oliveira LPG; de Assis Golim M; Uribe JFC; Gutiérrez RM; Buitrago MR; Popova M; Trusheva B; Bankova V; García OT; Sforcin JM
Phytother Res; 2019 Mar; 33(3):591-601. PubMed ID: 30488503
[TBL] [Abstract][Full Text] [Related]
10. Selective Cytotoxicity of Portuguese Propolis Ethyl Acetate Fraction towards Renal Cancer Cells.
Freitas AS; Costa M; Pontes O; Seidel V; Proença F; Cardoso SM; Oliveira R; Baltazar F; Almeida-Aguiar C
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807247
[TBL] [Abstract][Full Text] [Related]
11. Chinese Propolis Exerts Anti-Proliferation Effects in Human Melanoma Cells by Targeting NLRP1 Inflammatory Pathway, Inducing Apoptosis, Cell Cycle Arrest, and Autophagy.
Zheng Y; Wu Y; Chen X; Jiang X; Wang K; Hu F
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30149677
[TBL] [Abstract][Full Text] [Related]
12. NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth.
Kaoud TS; Mohassab AM; Hassan HA; Yan C; Van Ravenstein SX; Abdelhamid D; Dalby KN; Abdel-Aziz M
Eur J Med Chem; 2020 Jan; 186():111885. PubMed ID: 31784187
[TBL] [Abstract][Full Text] [Related]
13. Activities of multiple cancer-related pathways are associated with BRAF mutation and predict the resistance to BRAF/MEK inhibitors in melanoma cells.
Liu D; Liu X; Xing M
Cell Cycle; 2014; 13(2):208-19. PubMed ID: 24200969
[TBL] [Abstract][Full Text] [Related]
14. Aloe-emodin exerts a potent anticancer and immunomodulatory activity on BRAF-mutated human melanoma cells.
Tabolacci C; Cordella M; Turcano L; Rossi S; Lentini A; Mariotti S; Nisini R; Sette G; Eramo A; Piredda L; De Maria R; Facchiano F; Beninati S
Eur J Pharmacol; 2015 Sep; 762():283-92. PubMed ID: 26048310
[TBL] [Abstract][Full Text] [Related]
15. Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells.
Garay T; Kenessey I; Molnár E; Juhász É; Réti A; László V; Rózsás A; Dobos J; Döme B; Berger W; Klepetko W; Tóvári J; Tímár J; Hegedűs B
PLoS One; 2015; 10(2):e0117021. PubMed ID: 25646931
[TBL] [Abstract][Full Text] [Related]
16. Portuguese propolis disturbs glycolytic metabolism of human colorectal cancer in vitro.
Valença I; Morais-Santos F; Miranda-Gonçalves V; Ferreira AM; Almeida-Aguiar C; Baltazar F
BMC Complement Altern Med; 2013 Jul; 13():184. PubMed ID: 23870175
[TBL] [Abstract][Full Text] [Related]
17. A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.
Graziani G; Artuso S; De Luca A; Muzi A; Rotili D; Scimeca M; Atzori MG; Ceci C; Mai A; Leonetti C; Levati L; Bonanno E; Tentori L; Caccuri AM
Biochem Pharmacol; 2015 May; 95(1):16-27. PubMed ID: 25795251
[TBL] [Abstract][Full Text] [Related]
18. Cudraflavone C Induces Apoptosis of A375.S2 Melanoma Cells through Mitochondrial ROS Production and MAPK Activation.
Lee CW; Yen FL; Ko HH; Li SY; Chiang YC; Lee MH; Tsai MH; Hsu LF
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703746
[TBL] [Abstract][Full Text] [Related]
19. An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential.
Wang L; Leite de Oliveira R; Huijberts S; Bosdriesz E; Pencheva N; Brunen D; Bosma A; Song JY; Zevenhoven J; Los-de Vries GT; Horlings H; Nuijen B; Beijnen JH; Schellens JHM; Bernards R
Cell; 2018 May; 173(6):1413-1425.e14. PubMed ID: 29754815
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of radical scavenging activity, intestinal cell viability and antifungal activity of Brazilian propolis by-product.
de Francisco L; Pinto D; Rosseto H; Toledo L; Santos R; Tobaldini-Valério F; Svidzinski T; Bruschi M; Sarmento B; Oliveira MBPP; Rodrigues F
Food Res Int; 2018 Mar; 105():537-547. PubMed ID: 29433245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
